These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 32480370)

  • 1. Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution.
    Haddad AF; Young JS; Oh T; Pereira MP; Joshi RS; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Chopra AS; Sandhu NS; Theodosopoulos PV; Kunwar S; El-Sayed IH; Gurrola J; Blevins LS; Aghi MK
    Neurosurg Focus; 2020 Jun; 48(6):E13. PubMed ID: 32480370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics.
    Balogun JA; Monsalves E; Juraschka K; Parvez K; Kucharczyk W; Mete O; Gentili F; Zadeh G
    Endocr Pathol; 2015 Mar; 26(1):63-70. PubMed ID: 25403448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
    Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
    World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: a case series from two pituitary centers.
    Almeida JP; Stephens CC; Eschbacher JM; Felicella MM; Yuen KCJ; White WL; Mooney MA; Bernat AL; Mete O; Zadeh G; Gentili F; Little AS
    Pituitary; 2019 Oct; 22(5):514-519. PubMed ID: 31401793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical pituitary adenoma: a clinicopathologic case series.
    Rutkowski MJ; Alward RM; Chen R; Wagner J; Jahangiri A; Southwell DG; Kunwar S; Blevins L; Lee H; Aghi MK
    J Neurosurg; 2018 Apr; 128(4):1058-1065. PubMed ID: 28598278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes in elderly patients undergoing transsphenoidal surgery for nonfunctioning pituitary adenoma.
    Pereira MP; Oh T; Joshi RS; Haddad AF; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Gurrola J; El-Sayed IH; Blevins LS; Theodosopoulos PV; Kunwar S; Aghi MK
    Neurosurg Focus; 2020 Oct; 49(4):E19. PubMed ID: 33002877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging.
    Lee JYK; Cho SS; Zeh R; Pierce JT; Martinez-Lage M; Adappa ND; Palmer JN; Newman JG; Learned KO; White C; Kharlip J; Snyder P; Low PS; Singhal S; Grady MS
    J Neurosurg; 2018 Aug; 129(2):390-403. PubMed ID: 28841122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary surgery and volumetric assessment of extent of resection: a paradigm shift in the use of intraoperative magnetic resonance imaging.
    Serra C; Burkhardt JK; Esposito G; Bozinov O; Pangalu A; Valavanis A; Holzmann D; Schmid C; Regli L
    Neurosurg Focus; 2016 Mar; 40(3):E17. PubMed ID: 26926057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten years' experience with intraoperative MRI-assisted transsphenoidal pituitary surgery.
    Hlaváč M; Knoll A; Mayer B; Braun M; Karpel-Massler G; Etzrodt-Walter G; Coburger J; Wirtz CR; Paľa A
    Neurosurg Focus; 2020 Jun; 48(6):E14. PubMed ID: 32480376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery-a retrospective, single-center study.
    Sumislawski P; Huckhagel T; Krajewski KL; Aberle J; Saeger W; Flitsch J; Rotermund R
    Sci Rep; 2023 Feb; 13(1):2468. PubMed ID: 36774403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographic and clinical outcomes using intraoperative magnetic resonance imaging for transsphenoidal resection of pituitary adenomas.
    Juthani RG; Reiner AS; Patel AR; Cowan A; Roguski M; Panageas KS; Geer EB; Karimi S; Cohen MA; Tabar V
    J Neurosurg; 2021 Jun; 134(6):1824-1835. PubMed ID: 32619972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling.
    Madsen H; Borges TM; Knox AJ; Michaelis KA; Xu M; Lillehei KO; Wierman ME; Kleinschmidt-DeMasters BK
    Am J Surg Pathol; 2011 Aug; 35(8):1204-13. PubMed ID: 21753697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and Benefits of Endoscopic Transsphenoidal Surgery for Nonfunctioning Pituitary Adenomas in Patients of the Ninth Decade.
    Chinezu R; Fomekong F; Lasolle H; Trouillas J; Vasiljevic A; Raverot G; Jouanneau E
    World Neurosurg; 2017 Oct; 106():315-321. PubMed ID: 28676462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic Endonasal Pituitary Surgery For Nonfunctioning Pituitary Adenomas: Long-Term Outcomes and Management of Recurrent Tumors.
    Bernat AL; Troude P; Priola SM; Elsawy A; Farrash F; Mete O; Ezzat S; Asa SL; De Almeida J; Vescan A; Monteiro E; Almeida JP; Zadeh GM; Gentili F
    World Neurosurg; 2021 Feb; 146():e341-e350. PubMed ID: 33203535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic Transsphenoidal Surgery Outcomes in 331 Nonfunctioning Pituitary Adenoma Cases After a Single Surgeon Learning Curve.
    Kim JH; Lee JH; Lee JH; Hong AR; Kim YJ; Kim YH
    World Neurosurg; 2018 Jan; 109():e409-e416. PubMed ID: 29017983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience.
    Langlois F; Lim DST; Varlamov E; Yedinak CG; Cetas JS; McCartney S; Dogan A; Fleseriu M
    Endocrine; 2017 Dec; 58(3):528-534. PubMed ID: 29043561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients.
    Lampropoulos KI; Samonis G; Nomikos P
    Hormones (Athens); 2013; 12(2):254-64. PubMed ID: 23933694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Importance of Long Term Follow Up After Endoscopic Pituitary Surgery: Durability of Results and Tumor Recurrence.
    Almeida JP; Tabasinejad R; Kalyvas A; Takami H; Mohan N; O'Halloran PJ; Sanchez MM; Velasquez C; Zadeh G; Gentili F
    Neurol India; 2020; 68(Supplement):S92-S100. PubMed ID: 32611898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonfunctioning pituitary adenomas in pediatric and adolescent patients: a clinical analysis of a series of 14 patients.
    Wang H; Wang R; Hu T; Wang Z; Duan Y; Han S; Wu A
    J Neurooncol; 2020 May; 148(1):179-186. PubMed ID: 32333187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.
    Juraschka K; Khan OH; Godoy BL; Monsalves E; Kilian A; Krischek B; Ghare A; Vescan A; Gentili F; Zadeh G
    J Neurosurg; 2014 Jul; 121(1):75-83. PubMed ID: 24785323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.